Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
Treatment with a common antibiotic reduces the risk of life-threatening infections in ANCA-associated vasculitis patients being given Rituxan (rituximab) for their condition, a study conducted in the U.K. and Austria reports. This ... Read more
A noninvasive and simple ultrasound test might be a new tool to help predict artery damage and increased risk of cardiovascular events in ANCA-associated vasculitis patients with granulomatosis with ... Read more
Classifying the specificity of ANCA autoantibodies may complement the currently used clinical classification system when predicting the course of disease and prognosis in ANCA-associated vasculitis (AAV) patients with renal involvement, ... Read more
Patients with ANCA-associated glomerulonephritis receiving immunosuppressive therapy are not more likely to develop cancer than the general population, a study found. However, researchers did find that the risk for blood, post-transplant, and nonmelanoma ... Read more
Diverse clinical manifestations in patients with granulomatosis with polyangiitis can delay diagnosis and treatment, leading to high mortality rates, a study reports. These findings highlight the importance of early diagnosis for ... Read more
Pin It on Pinterest